Literature DB >> 21161618

Vincristine-resistant Kasabach-Merritt phenomenon successfully treated with low-dose radiotherapy.

Yuko Watanabe, Masaei Onuma, Chung Y Looi, Yuka Saito, Hiroshi Kitazawa, Hidetaka Niizuma, Takeshi Rikiishi, Osamu Sakamoto, Yoji Sasahara, Satoru Kumaki, Mika Watanabe, Shigeko Ushio, Shigeru Tsuchiya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21161618     DOI： 10.1007/s12185-010-0740-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

Review 1.  Kasabach-Merritt syndrome: pathogenesis and management.

Authors:  G W Hall
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

2.  Successful treatment with vincristine of an infant with intractable Kasabach-Merritt syndrome.

Authors:  Masashi Taki; Chiai Ohi; Atsuki Yamashita; Miwako Kobayashi; Noriaki Kobayashi; Takashi Yoda; Takeshi Horiuchi; Miho Aikyou; Yasuo Horikoshi; Junichi Mimaya
Journal:  Pediatr Int       Date:  2006-02       Impact factor: 1.524

3.  Radiation therapy for life- or function-threatening infant hemangioma.

Authors:  I Ogino; K Torikai; S Kobayasi; N Aida; M Hata; H Kigasawa
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

4.  Outcome of radiation therapy for patients with Kasabach-Merritt syndrome.

Authors:  N Mitsuhashi; M Furuta; H Sakurai; T Takahashi; S Kato; M Nozaki; Y Saito; K Hayakawa; H Niibe
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-09-01       Impact factor: 7.038

Review 5.  Kasabach-merritt syndrome.

Authors:  Sheilagh Maguiness; Lyn Guenther
Journal:  J Cutan Med Surg       Date:  2002-04-15       Impact factor: 2.092

6.  Successful treatment of Kasabach-Merritt syndrome with vincristine and diagnosis of the hemangioma using three-dimensional imaging.

Authors:  Keiichi Hara; Tomoaki Yoshida; Teruyuki Kajiume; Norioki Ohno; Hiroshi Kawaguchi; Masao Kobayashi
Journal:  Pediatr Hematol Oncol       Date:  2009 Jul-Aug       Impact factor: 1.969

7.  Vincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma.

Authors:  Aaron M Drucker; Elena Pope; Sanjay Mahant; Miriam Weinstein
Journal:  J Cutan Med Surg       Date:  2009 May-Jun       Impact factor: 2.092

8.  Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine.

Authors:  Camille Haisley-Royster; Odile Enjolras; Ilona J Frieden; Maria Garzon; Margaret Lee; Arnold Oranje; Peter C J de Laat; Gerard C Madern; Francisco Gonzalez; Hayder Frangoul; Philippe Le Moine; Neil S Prose; Denise M Adams
Journal:  J Pediatr Hematol Oncol       Date:  2002 Aug-Sep       Impact factor: 1.289

9.  Treatment of Kasabach-Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon.

Authors:  Siriwan Wananukul; Issaraang Nuchprayoon; Panya Seksarn
Journal:  Int J Dermatol       Date:  2003-09       Impact factor: 2.736
  9 in total
  2 in total

1.  Kasabach-Merritt Syndrome Associated With a Large Cavernous Splenic Hemangioma Treated With Splenectomy: A Surgeon's Introspection of an Uncommon, Little Read, and Yet Complex Problem-Review Article.

Authors:  Parvez David Haque; Amit Mahajan; Navneet Kumar Chaudhary; Deepak Jain
Journal:  Indian J Surg       Date:  2015-03-24       Impact factor: 0.656

2.  Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literature.

Authors:  Si-Ming Yuan; Wei-Min Shen; Hai-Ni Chen; Zhi-Jian Hong; Hui-Qing Jiang
Journal:  Int J Clin Exp Med       Date:  2015-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.